COMS

Scheduled for September 12 - 13, 2013 in Sacramento, CA, ICG Americas-II is modeled after BGI’s International Conferences on Genomics held annually since 2006 in China, which is regarded as one of the top scientific gatherings that features recent developments in genome sciences. The confernece is uniquely formatted to maximize opportunities to interact directly with other genomics industry luminaries, scientific thought leaders, key decision makers, top pharmaceutical executives, and influential policy makers.

Conveniently located in Sacramento, California’s capital is close to major destinations for business and pleasure - such as high-tech Silicon Valley, culturally fused San Francisco, and wine connoisseur’s dream, scenic Napa Valley. The ICG Americas-II venue offers an environment conducive to information exchange, generation of new ideas and acceleration of applications that benefit the life sciences.

Understanding the cellular and molecular events underpinning such synaptic dysfunction is a key goal if we are to halt or even reverse the inexorable deterioration currently observed in these conditions. Accordingly, much insight has already been gleaned on the genetics, protein misfolding, cell death pathways and mitochondrial involvement in chronic neurodegenerative diseases. From this insight has come greater knowledge of the fundamentals of synaptic function, but more so an appreciation of the potential, not only for drug-based therapies, but also biological treatments, for example via stem cells.

This conference will bring together world experts addressing the very mechanisms of neurodegeneration and the prospects for treatments that such knowledge promises.